Site Members can sign up for company wide alerts
Lawsuit Overview
November 7, 2022 - An amended complaint was filed. December 10, 2021 - An investor in shares of Revance Therapeutics, Inc. (NASDAQ: RVNC) filed a lawsuit in the U.S. District Court for the Northern District of California over alleged violations of Federal Securities Laws by Revance Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between Nov...
You must register (for free) or login to view the entire case.